Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Double-Blind Study of S-2367 in Obese Patients with Hypertension and Dyslipidemia
jRCT2080221085Phase 2
- Sponsor
- Shionogi & Co., Ltd.
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of velneperit in obesity, hypertension (HTN) and dyslipidemia, sponsored by Shionogi & Co., Ltd.
02
Drugs
velneperit
03
Conditions
obesityhypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on jRCT2080221085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221085.